Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Age, sex, and specific gene mutations affect the effects of immune checkpoint inhibitors in colorectal cancer.

Pharmacological research - 1 Sept 2020

Lin Anqi, Zhang Hongman, Hu Xigang, Chen Xiaoting, Wu Gang, Luo Peng, Zhang Jian

Abstract excerpt

The effect of age and sex on the predictive value of colorectal cancer (CRC) patients treated with immune checkpoint inhibitors (ICIs) has been controversial, and the effect of specific gene mutations on the predictive value of CRC patients treated with ICIs remains to be explored. Our study analyzed the influence of the above factors on the overall survival (OS) of CRC patients receiving ICIs and explored the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adenocarcinoma
Share to Age Factors
Share to Biomarkers, Tumor

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Colorectal Neoplasms

Share to Computational Biology

Share to Immune Checkpoint Inhibitors

Share to Sex Factors

Share to Tumor Microenvironment

Source

Identifiers

PMID: 32569820
DOI: 10.1016/j.phrs.2020.105028

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Age, sex, and specific gene mutations affect the effects of immune checkpoint inhibitors in colorectal cancer.PMID 32569820Read ↗

A Mutational Signature that Predicts Prognosis and Benefit of Immune Checkpoint Blockade in Colorectal CancerSemantic proximity Read ↗

Predictive molecular markers for the treatment with immune checkpoint inhibitors in colorectal cancerSemantic proximity Read ↗

Mutations Status of NOTCH Signaling Pathway Predict Prognosis of Immune Checkpoint Inhibitors in Colorectal CancerSemantic proximity Read ↗

An immune-related prognostic risk model for colorectal cancer was constructed based on next-generation sequencingSemantic proximity Read ↗

Rnf43 Mutation As A Biomarker For Immune Checkpoint Inhibitor Efficacy In Colorectal CancerSemantic proximity Read ↗

Multi-omics-based analysis of the effect of longevity genes on the immune relevance of colorectal cancerSemantic proximity Read ↗

Comprehensive Analysis of Subtype-Specific Molecular Characteristics of Colon Cancer: Specific Genes, Driver Genes, Signaling Pathways, and Immunotherapy ResponsesSemantic proximity Read ↗

Epigenetic-related gene mutations serve as potential biomarkers for immune checkpoint inhibitors in microsatellite-stable colorectal cancer.Semantic proximity Read ↗

Analyzing and validating the prognostic value and mechanism of colon cancer immune microenvironmentSemantic proximity Read ↗

Integrating tumor mutational burden and transcriptome expression into prediction of immune checkpoint inhibitor response and prognosis of patients with colon cancer.Semantic proximity Read ↗

The Demographic Profile of Colorectal Cancer Patients in Indonesia: Insights from a Single Center Experience and Exploration of Immune Response and Survival OutcomesSemantic proximity Read ↗

Prediction and identification of immune genes related to the prognosis of patients with colon adenocarcinoma and its mechanismsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.